Selective serotonin reuptake inhibitor use during pregnancy and maternal depression—a nationwide birth cohort study on risks to the mother and the newborn
SSRI use during pregnancy affects neonatal health beyond maternal depression by increasing symptoms related to delayed neonatal adaptation, although it may reduce the risk of preterm birth. The observed increase in the risk of gestational diabetes warrants further study. VIDEO ABSTRACT.
Authors
- Ian W. McKeague (ORCID: https://orcid.org/0000-0003-3962-7217)
- Aleksi Tornio (ORCID: https://orcid.org/0000-0001-5713-5692)
- Subina Upadhyaya (ORCID: https://orcid.org/0000-0001-6126-5561)
- Susanna Hinkka‐Yli‐Salomäki (ORCID: https://orcid.org/0000-0001-7785-9196)
- Keely Cheslack‐Postava (ORCID: https://orcid.org/0000-0001-7945-407X)
- David Gyllenberg (ORCID: https://orcid.org/0000-0003-3220-9805)
- Emmi Heinonen
- Heli Malm
- Mika Gissler
- Alan S. Brown
Institutions
- Research Council of Finland (FI)
- University of Helsinki (FI)
- Turku Centre for Computer Science (FI)
- Columbia University Irving Medical Center (US)
- Turku University Hospital (FI)
- New York Psychoanalytic Society and Institute (US)
- Columbia University (US)
Publication Details
- Journal
- American Journal of Obstetrics & Gynecology MFM
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1016/j.ajogmf.2026.101910
- Primary Topic
- Maternal Mental Health During Pregnancy and Postpartum
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute of Mental Health